Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification
For oral semaglutide (Rybelsus), follow the strict administration requirements: take on an empty stomach when you first wake up, with no more than 4 ounces of plain water, and wait at least 30 minutes before eating, drinking, or taking other oral medications
Berberine can cause digestive issues like diarrhoea, constipation, excess gas, and an upset stomach
C., Fernndez Land, L., Bergman, B
For some patients, yes